A PROSPECTIVE, CONTROLLED, DOUBLE BLIND, MULTI-CENTER, RANDOMIZED, 3 ARM, PHASE 1B/2A STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF B244 DELIVERED AS AN INTRANASAL SPRAY IN HEALTHY VOLUNTEERS AND SUBJECTS WITH SEASONAL ALLERGIC RHINITIS

Registry ID

18-PY-001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

AOBIOME LLC

Start date

2018-10-30

Last update

2018-10-18

Conditions

• RHINITIS

Related clinical trials

• A PHASE 2, RENDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY IN REDUCING NASAL ALLERGEN CHALLENGE PROVOKED SYMPTOMS OF TREATMENT WITH DM-101PX IN ADULTS WITH BIRCH POLLEN ALLERGIC RHINITIS OR RHINOCONJUNCTIVITIS
• TEZEPELUMAB IN THE TREATMENT OF CO-MORBID ALLERGIC RHINITIS AND ALLERGIC ASTHMA STUDY (TEZARS) - AN OPEN-LABEL EXPLORATORY MECHANISTIC PILOT STUDY TO EVALUATE TEZEPELUMAB EFFICACY IN ASTHMA AND ALLERGIC RHINITIS
• "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF STG320 SUBLINGUAL TABLETS OF HOUSE DUST MITE (HDM) ALLERGEN EXTRACTS IN ADULTS AND ADOLESCENTS WITH HDM-ASSOCIATED ALLERGIC RHINITIS."

View on source registry